Product Program year 2025 Source: CMS Open Payments

Oasis

Device Extra Cellular Matrix

PDI 00827002352421

Open in the dashboard

General payments

$134,563

1,306 payments

Research payments

$0

0 payments

Through program year 2025, $134,563 in general payments and $0 in research payments were reported against Oasis (Extra Cellular Matrix).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $73,487 530
2024 General $32,121 363
2023 General $23,540 322
2022 General $5,414 91

Breakdown

Who paid General payments · program years 2022–2025
  1. Smith+Nephew, Inc. $134,563 1,306 payments
Top recipients General payments · program year 2025
  1. Lourdes Castanon Surgical Critical Care · Monroeville, PA $7,275 10% · 1 payment
  2. Rajiv Sood Plastic and Reconstructive Surgery · Augusta, GA $6,988 10% · 1 payment
  3. Zachary Bauman Surgical Critical Care · Omaha, NE $6,385 9% · 3 payments
  4. Louis Ferrari Surgery · Phoenix, AZ $6,119 8% · 1 payment
  5. Kelly James Surgery · Independence, MO $5,813 8% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Surgery $15,568 22% · 46 practitioners
  2. Surgical Critical Care Surgery $14,130 20% · 9 practitioners
  3. Plastic and Reconstructive Surgery Surgery $9,357 13% · 7 practitioners
  4. Podiatrist, Foot & Ankle Surgery Podiatrist $9,313 13% · 98 practitioners
  5. Podiatrist $5,662 8% · 57 practitioners

The top 5 of 41 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Pennsylvania $23,196 32% · 139 recipients
  2. Georgia $14,289 19% · 8 recipients
  3. Nebraska $6,385 9% · 1 recipient
  4. Arizona $6,119 8% · 1 recipient
  5. Missouri $5,895 8% · 3 recipients

The top 5 of 29 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,306 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record